title: Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome.
abstract: There have been very few studies assessing the long-term physiological effects of nasal continuous positive airway pressure (CPAP) for the obstructive sleep apnoea syndrome. We therefore investigated prospectively the evolution of lung function, arterial blood gases and pulmonary haemodynamics in patients with this syndrome treated with CPAP. Sixty five patients were included. The mean duration of home treatment with nasal CPAP was 64+/-6 months. Most of the patients (77%) were smokers at the baseline assessment. We observed a small, but significant, decrease in forced expiratory volume in one second (FEV1) from 80+/-21% at baseline (t0) to 76+/-21% of the predicted value at the follow-up evaluation (t5) (p<0.01). Arterial oxygen tension (P[a,O2]) for the group as a whole remained stable (9.4+/-1.5 kPa (71+/-11 mmHg) versus 9.4+/-1.2 kPa (71+/-9 mmHg)). However, P(a,O2) increased in the subgroup of patients with hypoxaemia at t0 (n=23), from 7.8+/-0.7 kPa (59+/-5 mmHg) to 8.9+/-1.2 kPa (67+/-9 mmHg). Arterial carbon dioxide tension (P[a,CO2]) for the group as a whole increased slightly, but significantly, from 5.2+/-0.7 kPa (39+/-5 mmHg) to 5.4+/-0.5 kPa (41+/-4 mmHg) (p<0.05). Mean pulmonary artery pressure (Ppa) at rest did not change (16+/-5 mmHg versus 17+/-5 mmHg; NS) nor did exercising Ppa. In the 11 patients with pulmonary hypertension at t0, Ppa was 24+/-5 mmHg at t0 versus 20+/-7 mmHg at t5 (NS). We conclude that the significant decrease of forced expiratory volume in one second after 5 yr follow-up was related to a high percentage of smokers and exsmokers in the study population. Daytime arterial oxygen tension and pulmonary artery pressure remained stable in an unselected series of 65 obstructive sleep apnoea syndrome patients treated for 5 yrs with nasal continuous positive airway pressure, unlike arterial carbon dioxide tension, which increased by a small, but significant, amount.
authors.affiliation: Dept of Respiratory Medicine, University Hospital Strasbourg, France.
authors.forename: A
authors.initials: A
authors.lastname: Chaouat
authors.forename: E
authors.initials: E
authors.lastname: Weitzenblum
authors.forename: R
authors.initials: R
authors.lastname: Kessler
authors.forename: M
authors.initials: M
authors.lastname: Oswald
authors.forename: E
authors.initials: E
authors.lastname: Sforza
authors.forename: M N
authors.initials: MN
authors.lastname: Liegeon
authors.forename: J
authors.initials: J
authors.lastname: Krieger
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006699:Home Care Services; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D011175:Positive-Pressure Respiration / Q000379:methods; D011446:Prospective Studies; D011652:Pulmonary Circulation / Q000502:physiology; D012129:Respiratory Function Tests; D012307:Risk Factors; D012891:Sleep Apnea Syndromes / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D012907:Smoking / Q000503:physiopathology; D013997:Time Factors